Why We Need Better Checks on Genomic AI Interpretability

AI models have cracked a code many thought unbreakable: the human genome. But as the models get better, biologists want more than just predictions. They need to know why these predictions are made. And that's where things get messy.

The Problem with Anecdotal Validation

Interpretable machine learning (IML) is supposed to help bridge this gap between prediction and understanding. But here's the catch: most of what we've are isolated success stories. Researchers often lean on a single IML method, cherry-picking results that look good. The real problem? These methods can spit out opposing explanations for the same outcome. It's like asking two weather forecasts if it'll rain and getting a yes and no.

Even worse, these methods sometimes miss known regulatory motifs, the bread and butter of genomic science. If they can't even spot these, are they really reflecting what the model is doing inside its digital brain?

Time for a Rethink: Borrowing from Medicine

So, what do we do about this? The study suggests taking a page from clinical trials. Medicine doesn't gamble on anecdotal evidence. It relies on rigor and consistency. Genomic AI needs a similar framework that demands thorough testing and adverse-event reporting, not just stories that fit the narrative.

Why not apply a tiered system to evaluate these IML methods? The aim is to move beyond hand-picked results, emphasizing consistency and biological validity. This isn't just about making AI better. It's about ensuring it tells the truth, every time.

Why This Matters

AI in genomics isn't just some academic exercise. These models have the potential to revolutionize medicine, tailoring treatments and uncovering unknown genetic links. But if we can't trust the explanations they give, what's the point?

Are we content with a digital oracle that sometimes speaks the truth or do we demand a reliable guide? genomics, accuracy isn't a luxury. It's a necessity. If you haven't questioned the AI's rationale, you're trusting blindly. And that's a risk we can't afford to take.